On November 10, 2023 Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, reported that the Company will present at the Sidoti November Micro Cap Conference taking place November 15-16, 2023 (Press release, Precision Biosciences, NOV 10, 2023, View Source [SID1234637465]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for the presentation are as follows:

Date: November 15, 2023
Time: 10:45 AM ET

The presentation will be available on Precision’s website under the Investors section under Events & Presentations on November 15, 2023 at investor.precisionbiosciences.com. An archived replay will be available for approximately 30 days following the event.